Seeking Alpha

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S....

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S. patent office for a patent covering the use of its NeuVax product candidate, a vaccine for inducing immunity to breast cancer recurrence in some patients. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs